News

AbbVie announced it has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's neuroscience portfolio. This acquisition gives AbbVie access to Syndesi's portfolio of novel modulators of the synaptic vesicle protein 2A (SV2A), including its...

IDT Biologika, a leading Contract Development and Manufacturing Organization (CDMO) specialized in vaccines, gene and immune therapy and oncolytic viruses, and Exothera S.A. collaborate to develop a large-scale manufacturing process for viral vector-based vaccines. The feasibility study is focussing...

The U.S. Food and Medication Administration authorised CTI BioPharma Corp's drug for treating adult patients with a kind of bone marrow cancer who also have a low blood platelet count. Vonjo (pacritinib) belongs to a class of anti-inflammatory drugs...

INCOG BioPharma Services announces it has completed the construction of its Quality Control testing laboratories, as well as the technology transfer and scale-up suite, at its headquarters in Fishers, Indiana. Shortly after INCOG employees moved into their new offices,...

Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has entered into a definitive agreement with its partner Viatris Inc. Accordingly, Biocon Biologics Ltd. (BBL) will acquire Viatris’ biosimilars business to create a unique fully integrated global...

Biohaven Pharmaceutical Holding Company Ltd. announced that it entered into a worldwide license agreement with Bristol Myers Squibb for the development and commercialization rights to taldefgrobep alfa, a novel, Phase 3-ready anti-myostatin adnectin. Taldefgrobep is the third development asset...

Mirus Bio, a leading provider of delivery solutions within Gamma Biosciences, today launched TransIT-VirusGEN® SELECT Transfection Kits for large-scale viral vector production for cell and gene therapy applications. The kits support pre-clinical and process development activities and consist of...